Filipovic B, Marjanovic-Haljilji M, Blagojevic D, Dragovic M, Krsmanovic E, Matovic A
Int J Mol Sci. 2025; 26(5).
PMID: 40076490
PMC: 11899773.
DOI: 10.3390/ijms26051863.
Zhu B, Chen S, Li X, Huang S, Luo Z, Zhang W
Sci Rep. 2025; 15(1):4783.
PMID: 39922875
PMC: 11807099.
DOI: 10.1038/s41598-025-89272-x.
Amer B, Khozaigi W, Hawshab L, Hawshab F, Khozaigi K, Darwesh K
Cureus. 2025; 17(1):e77023.
PMID: 39912050
PMC: 11798579.
DOI: 10.7759/cureus.77023.
Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z
Signal Transduct Target Ther. 2025; 10(1):33.
PMID: 39904973
PMC: 11794951.
DOI: 10.1038/s41392-024-02072-z.
Engel B, Assis D, Bhat M, Clusmann J, Drenth J, Gerussi A
JHEP Rep. 2025; 7(2):101265.
PMID: 39897612
PMC: 11783120.
DOI: 10.1016/j.jhepr.2024.101265.
Diagnostic Performance of Shear-Wave Elastography in Autoimmune Hepatitis: Evaluating Baseline Characteristics and Accuracy Across Fibrosis Stages.
Rasool N, Hyder A, Tareen K, Ahmed I, Iqbal S, Kauser Siddiqui M
Cureus. 2025; 17(1):e76789.
PMID: 39897203
PMC: 11786780.
DOI: 10.7759/cureus.76789.
Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases.
Durazzo M, Ferro A, Navarro-Tableros V, Gaido A, Fornengo P, Altruda F
Biomolecules. 2025; 15(1).
PMID: 39858515
PMC: 11763965.
DOI: 10.3390/biom15010121.
Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study.
Kim J, Kim S, Song D, Kim H, Yoon E, Park J
Ann Med. 2025; 57(1):2428431.
PMID: 39856091
PMC: 11770857.
DOI: 10.1080/07853890.2024.2428431.
Glucocorticoid receptors: The key of the response to steroid therapy in autoimmune hepatitis.
El-Guindi M, Zakaria H, Taie D, Khedr M, Adawy N, Abd-Elaati B
Clin Exp Hepatol. 2025; 10(2):111-119.
PMID: 39845351
PMC: 11748230.
DOI: 10.5114/ceh.2024.140322.
Steroid-refractory immune mediated hepatitis managed with budesonide in patients with metastatic melanoma: proof of concept and literature review.
Kankaria R, Johnson D
Oncologist. 2025; 30(1).
PMID: 39832128
PMC: 11745016.
DOI: 10.1093/oncolo/oyae361.
Clinical and laboratory characteristics of Sjögren's syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study.
Liang P, Huang Y, Hu Z, Zhou L, Cai S, Zhong J
Clin Rheumatol. 2025; 44(3):1225-1236.
PMID: 39826046
DOI: 10.1007/s10067-024-07273-z.
A Case of Hepatitis in Pregnancy.
Alfred-Demas R, Daisley H, Dalrymple N, Alfred R, Thompson-Dillon A
Cureus. 2025; 16(12):e75861.
PMID: 39822480
PMC: 11736823.
DOI: 10.7759/cureus.75861.
Immediate management of a cirrhosis-induced severe pericardial effusion: a case report and review of the literature.
Taheri M, Dargah A, Ramezani P, Anafje M, Nasrollahizadeh A, Ebrahimi P
J Med Case Rep. 2025; 19(1):5.
PMID: 39780164
PMC: 11707975.
DOI: 10.1186/s13256-024-05016-x.
Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis.
Yang F, Ni B, Liang X, He Y, Yuan C, Chu J
Stem Cell Res Ther. 2025; 16(1):4.
PMID: 39773662
PMC: 11706160.
DOI: 10.1186/s13287-024-04013-7.
Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials.
Huang W, Li Y, Chen P, Ma K, Wang L
Stem Cell Res Ther. 2025; 16(1):3.
PMID: 39762946
PMC: 11705688.
DOI: 10.1186/s13287-024-04127-y.
Navigating Through the Course of Autoimmune Hepatitis in Adults: A Case-Series Exploration.
Awadhiya O, Rathod B, Khot R, Chaudhari S, Kamble N
Cureus. 2025; 16(12):e75152.
PMID: 39759723
PMC: 11699844.
DOI: 10.7759/cureus.75152.
Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide.
Protopapas A, Tsankof A, Papagiouvanni I, Kaiafa G, Skoura L, Savopoulos C
World J Hepatol. 2025; 16(12):1377-1394.
PMID: 39744202
PMC: 11686542.
DOI: 10.4254/wjh.v16.i12.1377.
Effects of Probiotics on Liver Diseases: Current In Vitro and In Vivo Studies.
Sadri M, Shafaghat Z, Roozbehani M, Hoseinzadeh A, Mohammadi F, Arab F
Probiotics Antimicrob Proteins. 2024; .
PMID: 39739162
DOI: 10.1007/s12602-024-10431-z.
A phase 1/2 safety and efficacy study of TAK-754 gene therapy: The challenge of achieving durable factor VIII expression in haemophilia A clinical trials.
Chapin J, Alvarez Roman M, Ayash-Rashkovsky M, Diogo D, Kenniston J, Lopez-Jaime F
Haemophilia. 2024; 31(1):108-117.
PMID: 39716875
PMC: 11780198.
DOI: 10.1111/hae.15121.
Liver Transplantation for Autoimmune Hepatitis: 20 Years of Tertiary Centre Experience.
Saglam O, Muhip Harputluoglu M, Bilgic Y, Yilmaz S, Yagin F, Efe C
Turk J Gastroenterol. 2024; 1(1).
PMID: 39696995
PMC: 11899994.
DOI: 10.5152/tjg.2024.24464.
